Pharmaconex is part of the Informa Markets Division of Informa PLC


Industry News

Stay ahead of the pack with our round-the-clock news service and thought leadership from industry experts. keeping you up-to-date with the latest developments and technological advancements in the Pharma industry.

U.S. adds 2.5 million Bavarian Nordic monkeypox vaccine doses, expects more in July

July 15 (Reuters) - The U.S. government has ordered an additional 2.5 million doses of Bavarian Nordic's (BAVA.CO) vaccine for use against monkeypox and expects more later this month to fight an outbreak of the viral disease. 


Source: Reuters

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022

The COVID-19 pandemic has changed the world – and the biopharma industry. The industry has adopted new technologies and approaches to drug development – and has learned that it is possible to bring new therapies to patients in significantly reduced timelines. 


Source: The Medicine Maker

Egypt Outpacing Middle East and Africa’s Top Markets

Four years after Egypt enacted a new universal health law, the country’s pharmaceutical market has consolidated itself as the fastest growing in the Middle East and Africa, far outpacing Saudi Arabia, South Africa, the UAE and Algeria. With USD 6.3 billion in value, Egyptian pharma is about to double its size from 2017. 


Source: Pharma Boardroom

Bavarian Nordic monkeypox vaccine wins EU approval

OSLO, July 25 (Reuters) - Danish biotechnology company Bavarian Nordic (BAVA.CO) said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA).


Source: Reuters

Five Key Trends in MEA Medtech

The Middle East and Africa (MEA) medtech market is expected to grow from a value of USD 16.6 billion in 2019 to USD 21.8 billion at a CAGR of 3.6 percent by 2027, according to Business Market Insights. Read on for five crucial trends impacting MEA medtech and how the industry stands to evolve in the coming years.


Source: Pharma Boardroom